HIV and AIDS Trial, Recruiting NCT06605053 Sponsor: Karolinska Institutet Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06605053
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Sub-study 1 (records-based analysis):

  • Young women and girls aged 15–24 living with HIV who were pregnant or had recently given birth, and who started HIV prevention services for pregnancy between January 1, 2018, and December 31, 2020.
  • Babies born to these young women during that same period.

Sub-study 2 (interviews/discussions):

  • Young women and girls aged 15–24 living with HIV who are currently pregnant, were previously pregnant or recently gave birth, or have never been pregnant.
  • Healthcare workers at clinics that provide HIV prevention services related to pregnancy.
  • Partners, spouses, parents of these young women, and community members involved in the study area.

Sub-study 3 (working together to develop solutions):

  • People who took part in Sub-study 2, including young women, healthcare workers, partners, spouses, parents, and community members.
  • Members of the research team.

Sub-study 4 (randomised trial):

  • Pregnant young women and girls aged 15–24 living with HIV — whether newly diagnosed, previously diagnosed, or transferring from another clinic — who are receiving routine HIV prevention care during pregnancy between January 1, 2026, and June 30, 2026, and can be followed for at least one year until June 30, 2027.

Who may not be able to join:

Sub-studies 1 and 4:

  • Young women whose HIV treatment (antiretroviral therapy) status was not recorded in their medical records.
  • Young women who had not yet started HIV treatment (Sub-study 1 only).

Sub-studies 2 and 3:

  • People who are severely unwell mentally or physically in a way that would prevent them from taking part in study activities.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0046707302287

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 October 2024
Est. completion
1 December 2027

Where this trial is recruiting

Tanzania

Primary endpoints

Time to ART attrition; Detectable viral load; HIV-free infant survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov